Attributions

Novel Gene-Therapy Approach for Glaucoma

Simon John, PhD Columbia University

Co-Principal Investigators

Krish Kizhatil, PhD

Summary

The project aims to develop and test resources for Schlemm’s canal specific targeting and expression of genes for gene therapy. Successful development of this targeted therapy will help control eye pressure more effectively and provide better treatment options for glaucoma patients.